VivoSeq
Other

Bunion

0

Pipeline Programs

1

Active Trials

6

Companies Involved

Bunion is an early-stage landscape with 0 programs across 6 companies. The most active players are AFT Pharmaceuticals, Ltd., Merck & Co., Pacira Pharmaceuticals, Inc.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

11/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

9

clinical trials

Completed7 · 78%
Not yet recruiting1 · 11%
Terminated1 · 11%

Trial Activity

9 trials

Phase 3 Bunionectomy Study (Placebo Controlled)
Not yet recruiting·CCali Pharmaceuticals LLC·Phase 3·NCT07490496·112 enrolled
Open-Label CA-008 (Vocacapsaicin) in Bunionectomy
Completed··Phase 2·NCT03885596·36 enrolled
Maxigesic IV Phase 3 Bunionectomy Study
Completed·AAFT Pharmaceuticals, Ltd.·Phase 3·NCT02689063·276 enrolled
Bunionectomy Study (0000-063)
Completed·Merck & Co. logoMerck & Co.·Phase 1·NCT00601458·100 enrolled
Bunionectomy Trial With GRT6005
Completed·TTris Pharma, Inc.·Phase 2·NCT00872885·258 enrolled
Study of CA-008 (Vocacapsaicin) in Bunionectomy Patients
Completed··Phase 2·NCT03599089·147 enrolled
Dose-Escalation Study of HTX-034 Following Bunionectomy
Completed·HHeron Therapeutics·Phase 1/2·NCT04398329·73 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)